The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

39 articles for BL Harrison


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel triazines as potent and selective phosphodiesterase 10A inhibitors.EBI
Pfizer
Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.EBI
Wyeth Research
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocket.EBI
Wyeth Research
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.EBI
Wyeth Research
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.EBI
Wyeth Research
Highly potent, selective, and orally active phosphodiesterase 10A inhibitors.EBI
Pfizer
Discovery of imidazo[1,5-a]pyrido[3,2-e]pyrazines as a new class of phosphodiesterase 10A inhibitiors.EBI
Biotie Therapies
The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonists.EBI
Pfizer
3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.EBI
Wyeth Pharmaceuticals
Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity.EBI
Wyeth Research
Synthesis and structure-activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT(1A) receptor and the serotonin transporter.EBI
Wyeth Research
1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-pyrrolopyridines are 5-HT(6) receptor ligands.EBI
Wyeth Research
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists.EBI
Wyeth Research
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists.EBI
Wyeth Research
Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives.EBI
Wyeth Research
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets.EBI
Wyeth Research
Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor.EBI
Wyeth Research
Breakthroughs in neuroactive steroid drug discovery.EBI
Sage Therapeutics
Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity.EBI
Wyeth Research
SAGE-718: A First-in-Class EBI
Sage Therapeutics
Novel human metabolites of the angiotensin-II antagonist tasosartan and their pharmacological effects.EBI
Wyeth Research
Neuroactive Steroid EBI
Sage Therapeutics
Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.EBI
Wyeth Research
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)EBI
Sage Therapeutics
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.EBI
Marion Merrell Dow Research Institute
METHODS FOR TREATMENT OF CANCERBDB
Frontier Medicines
PRMT5 INHIBITORS AND METHODS OF TREATMENTBDB
Hangzhou Unogen Biotech
THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDSBDB
Terns Pharmaceuticals
Bicyclic amide compounds and methods of use thereofBDB
Genentech
Tetrahydroisoquinoline derivatives, preparation process and use thereofBDB
Sichuan Kelun-Biotech Biopharmaceutical
Use of aminomethylenecyclohexane-1,3-dione compoundBDB
Wigen Biomedicine Technology (Shanghai)
N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancerBDB
Korea Research Institute of Chemical Technology
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsBDB
Ideaya Bioscience
Substituted benzamides as RIPK2 inhibitorsBDB
Boehringer Ingelheim International
Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeuticsBDB
Stingray Therapeutics
Amino pyrimidine compound for inhibiting protein tyrosine kinase activityBDB
Shenzhen Targetrx
Pyrimidine FGFR4 inhibitorsBDB
Eisai R&D Management
Inhibitors of lysine specific demethylase-1BDB
Celgene Quanticel Research
Incontinence treatment methodsBDB
Ixaltis